5Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
6Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
7Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
8Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
9Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microb, 2003, 41:3403-3406.
10Villers D, Espase E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med, 1998, 129: 182-189.
